0 results for 'Eli Lilly'
Pharma Company Sues to Block Blockchain Medical Platform From Using 'LY' for Cryptocurrency
This lawsuit was surfaced on Law.com Radar. Read the complaint here.
With Billions at Stake, Supreme Court Dips Its Toes Into Biologic Drug Patents
The justices have asked for the solicitor general's views on a cert petition by Amgen in a case that could reinterpret patent law's Section 112 and the law of enablement.
The Benefits, Consequences and Pitfalls of Terminal Disclaimers
A terminal disclaimer—a seemingly simple document that shortens a patent's life by declaring that it expires upon the expiration of another commonly owned patent—is replete with technical and substantive traps for the unwary and far-reaching consequences during both prosecution and enforcement of U.S. patents.
Federal Judge Allows Teva's Migraine Med Patent Lawsuit to Proceed Against Eli Lilly
Teva argues that Eli Lilly induced infringement of two of Teva's patents that protect the methods for administering the drug for the treatment of "refractory" migraines, or for patients who failed on at least two prior migraine preventative treatments.
Federal Circuit Underscores Importance of Written Description Requirement
'Biogen Int'l GMBH v. Mylan Pharms.' highlights the importance of considering invalidity under the written description requirement as a potential defense in litigation—particularly in ANDA cases, in which therapeutic efficacy for specific conditions, and drugs dosage amounts, may be at issue—and for patent applicants to remain mindful of written description pitfalls throughout patent prosecution.
Law Journal Press | Digital Book
America Invents Act (AIA) Handbook: A Guide to the Patent Law Reform of 2011, The, 2015 Edition
Authors: Mary Anthony Merchant
View this Book
View more book results for the query "Eli Lilly"
DeSantis Blasts FDA For Halting Drugs Ineffective on Omicron
The FDA says omicron is responsible for more than 99% of U.S. infections, making it "highly unlikely" that the antibodies would be effective for people seeking treatment.
Run It Back! One Last Look at the 2021 Litigators of the Week
Here's one last 'huzzah!' for this year's winners.
Health-Care Giant J&J to Split Into Drug, Consumer Companies
Johnson & Johnson is following in the footsteps of other big drugmakers that have moved to focus on the more-profitable pharmaceutical market.
See Who Passed the July 2021 New York Bar Exam
The New York State Board of Law Examiners examined 9,227 candidates during the July 27-28 examination. Of those candidates, 5,791 passed for an overall passing rate of 63%.
A Quiet US Supreme Court Term Ahead for IP—With One Potential Explosion
Stanford law professor Mark Lemley said he believes the justices would much prefer not to wade back into patent eligibility. But, he said, American Axle and Manufacturing v. Neapco "has an interesting spin because it will look to the justices like real technology, not the weak patents they have encountered before."Trending Stories
- 1AI: Looking at Its Impact on the Legal Profession in 2025 and Beyond
- 2Law.com's Top 100 Verdicts of 2023
- 3Joshua Wright Sues GMU for Alleged Title IX Violations, but Has $108M Defamation Suit Against Accusers Tossed
- 4In Wake of Sexual Misconduct Allegations Against Ex-Law Professor, GMU Bans Intimate Relationships With Students
- 5Updated Stanford Report Finds High Hallucination Rates on Westlaw AI
More from ALM
- Morgan & Morgan Class Action Attorneys Detail Pathway to Success Within Cybersecurity and Data Privacy Practice 1 minute read
- Holwell Shuster & Goldberg Partners Leverage 'Hostile' Witnesses to Secure $101 Million Verdict Against Walmart 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
Resources
Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House
Brought to you by LexisNexis®
Download Now
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now